Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure

Clinical trial NCT04642638 · TERMINATED

Trial details

NCT number: NCT04642638
Sponsor: Inovio Pharmaceuticals
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Coronavirus Infection Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)COVID-19 Disease

Start date: 2020-11-30
Primary completion: 2022-09-13
Enrollment: 1307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.